25.04.2013 | J-M Huang; I Nagatomo; E Suzuki; T Mizuno; T Kumagai; A Berezov; H Zhang; B Karlan; M I Greene; Q Wang, Oncogene, 2013

YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14 Oncogene 32, 2220 (25 April 2013). doi:10.1038/onc.2012.231 Authors: J-M Huang, I Nagatomo, E Suzuki, T Mizuno, T ...

mehr

21.02.2013 | K-W Cho; J H Park; C-W Park; D Lee; E Lee; D J Kim; K J Kim; S H Yoon; Y Park; E Kim; S Cho; S Jang; B-C Park; S-W C ..., Oncogene, 2013

Identification of a pivotal endocytosis motif in c-Met and selective modulation of HGF-dependent aggressiveness of cancer using the 16-mer endocytic peptide Oncogene 32, 1018 (21 February 2013). doi:10.1038/onc.2012.122 Authors: K-W Cho, J H Park, C-W Park, D Lee, E ...

mehr

07.02.2013 | A Peschiaroli; A Giacobbe; A Formosa; E K Markert; L Bongiorno-Borbone; A J Levine; E Candi; A D'Alessandro; L Zolla ..., Oncogene, 2013

miR-143 regulates hexokinase 2 expression in cancer cells Oncogene 32, 797 (7 February 2013). doi:10.1038/onc.2012.100 Authors: A Peschiaroli, A Giacobbe, A Formosa, E K Markert, L Bongiorno-Borbone, A J Levine, E Candi, A D'Alessandro, L Zolla, A Finazzi ...

mehr

07.02.2013 | P De Marco; V Bartella; A Vivacqua; R Lappano; M F Santolla; A Morcavallo; V Pezzi; A Belfiore; M Maggiolini, Oncogene, 2013

Insulin-like growth factor-I regulates GPER expression and function in cancer cells Oncogene 32, 678 (7 February 2013). doi:10.1038/onc.2012.97 Authors: P De Marco, V Bartella, A Vivacqua, R Lappano, M F Santolla, A Morcavallo, V Pezzi, A Belfiore & ...

mehr

03.12.2012 | T Adhikary, D T Brandt, K Kaddatz, J Stockert, S Naruhn, W Meissner, F Finkernagel, J Obert, S Lieber, M Scharfe, M ..., Oncogene, 2012

Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion Oncogene advance online publication, December 3 2012. doi:10.1038/onc.2012.549 Authors: T Adhikary, D T Brandt, K Kaddatz, J Stockert, S Naruhn, W Meissner, F ...

mehr

19.11.2012 | R A Copeland, M P Moyer, V M Richon, Oncogene, 2012

Targeting genetic alterations in protein methyltransferases for personalized cancer therapeutics Oncogene advance online publication, November 19 2012. doi:10.1038/onc.2012.552 Authors: R A Copeland, M P Moyer & V M Richon

mehr

08.11.2012 | B Li; M A Antonyak; J Zhang; R A Cerione, Oncogene, 2012

RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells Oncogene 31, 4740 (8 November 2012). doi:10.1038/onc.2011.636 Authors: B Li, M A Antonyak, J Zhang & R A Cerione

mehr

22.10.2012 | S-F Su, Y-W Chang, C Andreu-Vieyra, J Y Fang, Z Yang, B Han, A S Lee, G Liang, Oncogene, 2012

miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer Oncogene advance online publication, October 22 2012. doi:10.1038/onc.2012.483 Authors: S-F Su, Y-W Chang, C Andreu-Vieyra, J Y Fang, Z Yang, B ...

mehr

20.08.2012 | M Calao, E O Sekyere, H J Cui, B B Cheung, W D Thomas, J Keating, J B Chen, A Raif, K Jankowski, N P Davies, M V Bek ..., Oncogene, 2012

Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation Oncogene advance online publication, August 20 2012. doi:10.1038/onc.2012.368 Authors: M Calao, E O Sekyere, H J Cui, B B Cheung, W ...

mehr

09.07.2012 | T Kallunki, O D Olsen, M J|[auml]||[auml]|ttel|[auml]|, Oncogene, 2012

Cancer-associated lysosomal changes: friends or foes? Oncogene 32, 1995 (18 April 2013). doi:10.1038/onc.2012.292 Authors: T Kallunki, O D Olsen & M Jäättelä

mehr